Andrew Mitchell

Andrew Mitchell

Ask VT AI
View News Summary
  • Chime Financial, a leading U.S. neobank, files for Nasdaq IPO, highlighting growth and regulatory risks.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Topuria and Oliveira to headline UFC 317 in June 2025 for the vacant lightweight title, while Pantoja defends his flyweight belt against Kara-France in the co-main event.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Chime Financial, a leading U.S. neobank, files for Nasdaq IPO, highlighting growth and regulatory risks.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Topuria and Oliveira to headline UFC 317 in June 2025 for the vacant lightweight title, while Pantoja defends his flyweight belt against Kara-France in the co-main event.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Andrew Mitchell